Home » Topics » BioWorld Science

BioWorld Science
RSS

New cytokine biosynthesis inducers presented by 3M Pharmaceuticals

Sep. 19, 2019

Karus Therapeutics describes HDAC inhibitors

Sep. 19, 2019

Genentech identifies new SCN9A blockers

Sep. 19, 2019

SciFluor Life Sciences presents new integrin receptor antagonists

Sep. 19, 2019

U.S. researchers patent HLA DQ8 ligands

Sep. 19, 2019

Molecular Templates begins first-in-human study of MT-5111 in HER2-positive solid tumors

Sep. 19, 2019

Heidelberg Pharma's work in ETN MAGICBULLET project supported by new E.U. grant

Sep. 19, 2019

First-in-human study evaluates UB-312 in healthy subjects and patients with Parkinson's disease

Sep. 19, 2019

Study finds microbe drives CRC, identifies therapeutic target

Sep. 19, 2019

D-578 demonstrates antidepressant and anti-PTSD-like effects in vivo

Sep. 19, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...